The Subdural Hematoma Outcomes in a Population (SD HOP) Study
Project Number5K23NS121633-02
Former Number1K23NS121633-01
Contact PI/Project LeaderROBINSON, DAVID
Awardee OrganizationUNIVERSITY OF CINCINNATI
Description
Abstract Text
Project Summary/Abstract
In the United States, subdural hematomas (SDHs) are projected to become the most common cranial
neurosurgical condition by 2030. This has major public health implications, as nearly 50% of SDH patients are
dead or severely disabled at three months. Despite its importance, there is very little study of this disease at the
population-level, particularly with regard to outcomes after patients leave the hospital. Nearly 1 in 6 patients that survive
an initial SDH hospitalization are rehospitalized within 90 days, and this risk may be impacted heavily by social
determinants of health (SocDH). Regardless, there is no predictive model available to identify SDH survivors at high risk
of rehospitalization. Further, SDHs are tightly associated with premorbid antithrombotic use, and these medications are
commonly held at the time of presentation, but there is little evidence about the risks and benefits of antithrombotic
resumption in SDH survivors. To address these limitations, we will conduct the first population-level study of SDH
outcomes in the United States. We will accomplish this relatively quickly and at low cost by utilizing the well-validated
infrastructure of the Greater Cincinnati/Northern Kentucky Stroke Study, which has been studying population-level
outcomes in stroke and intracranial hemorrhage for more than 30 years. This infrastructure will allow us to determine
the 3-year risk of major ischemic and hemorrhagic events after an SDH and determine the predictors for each outcome.
We will also a build a predictive model of 90-day rehospitalization or death among SDH patients that utilizes both
clinical and SocDH variables. We will use conventional predictive modeling along with modern machine learning
techniques, allowing us to maximize predictive ability and potentially identify new variables and interactions that lead to
adverse outcomes in SDH survivors. Through this proposal, Dr. Robinson will become an expert in the epidemiology of
SDH and in the use of novel data science techniques to analyze large clinical databases. These skills will prepare him
to become the next PI of the overall Greater Cincinnati/Northern Kentucky Stroke Study. Dr. Robinson will conduct this
work under the guidance of a distinguished mentorship committee: Dr. Brett Kissela, a stroke epidemiologist with
expertise in using big data techniques; Dr. Dan Woo, a clinician scientist that studies disparities in intracerebral
hemorrhage; Opeolu Adeoye, a neurointensivist and researcher with expertise in acute care research; and Hooman
Kamel, a stroke epidemiologist and neurointensivist with expertise in the population-level study of SDHs.
Public Health Relevance Statement
Project Narrative
Subdural hematomas are a form of bleeding in the head that are becoming more common; they often require
surgery and can be fatal. We want to understand how this disease affects people weeks and months after the initial
event. By studying longer term outcomes, we hope to identify factors that could help future patients recover from this
disease.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AcuteAddressAffectAttentionBenefits and RisksBig DataBlood VesselsCase Fatality RatesCase SeriesCephalicCerebral hemisphere hemorrhageCessation of lifeChronicClinicalClinical DataComputerized Medical RecordCountyCraniocerebral TraumaData ScienceDeath RateDevelopmentDiagnosisDisabled PersonsDiseaseDisparityEpidemiologistEpidemiologyEpilepsyEthnic OriginEventFibrinolytic AgentsFutureGoalsHeadHematomaHemorrhageHospital MortalityHospitalizationHospitalsIncidenceIncidence StudyInformaticsInfrastructureInsuranceInsurance CoverageInternational Classification of Disease CodesIntracranial HemorrhagesIschemiaIschemic StrokeKentuckyMachine LearningMeasuresMedicaidMentorshipModelingModernizationMyocardial InfarctionOperative Surgical ProceduresOutcomeOutcome MeasurePatientsPersonsPharmaceutical PreparationsPhysiciansPopulationPopulation StudyPublic HealthRaceRandomized, Controlled TrialsRecurrenceResearchResearch PersonnelResourcesRiskScientistSeizuresStatus EpilepticusStrokeSubdural HematomaSurvivorsTechniquesTimeTraumaUnited StatesWorkacute careadverse outcomeclinical databasecostfollow-uphealth care availabilityhealth care disparityhigh riskhospital readmissionimprovedindexinglarge datasetsmachine learning algorithmneurosurgerynoveloutcome predictionpredictive modelingreadmission ratesskillssocial health determinantsstroke incidencestroke outcomethrombotic
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
041064767
UEI
DZ4YCZ3QSPR5
Project Start Date
01-March-2023
Project End Date
29-February-2028
Budget Start Date
01-March-2024
Budget End Date
28-February-2025
Project Funding Information for 2024
Total Funding
$238,905
Direct Costs
$223,855
Indirect Costs
$15,050
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Neurological Disorders and Stroke
$238,905
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K23NS121633-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K23NS121633-02
Patents
No Patents information available for 5K23NS121633-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K23NS121633-02
Clinical Studies
No Clinical Studies information available for 5K23NS121633-02
News and More
Related News Releases
No news release information available for 5K23NS121633-02
History
No Historical information available for 5K23NS121633-02
Similar Projects
No Similar Projects information available for 5K23NS121633-02